Company Profile
Company Introduction
　　Walvax Biotechnology Co., Ltd. (hereinafter referred to as Walvax) was founded in 2001, which is a modern biological pharmaceutical enterprise engaged in R & D, production and sales of bio-medicine products.
Products
  • Group ACYW135 Meningococcal Polysaccharide Vaccine（HALAL）
  • Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed
  • 23-valent Pneumococcal Polysaccharide Vaccine
  • Group ACYW135 Meningococcal Polysaccharide Vaccine
  • Group A and C Meningococcal Polysaccharide Vaccine
  • Group A, C Meningococcal Polysaccharide Conjugate Vaccine, Freeze-dried
  • Haemophilus Influenzae Type b Conjugate Vaccine (Prefilled syringe)
  • Haemophilus Influenzae Type b Conjugate Vaccine
捕鱼游戏怎么赚钱 彩票平台注册送19 澳洲幸运5计划人工稳版 快速赛车开奖网址 足彩胜负彩精准预测分析 97期p3试机号 新疆25选7预测 福建时时彩开奖结果查询 mg娱乐游戏平台官网 og真人电子|官网平台入口 快乐赛车开奖视频 广东时时彩投注娱乐城 山西快乐10分钟开奖结果 浙江20选5推荐预测 75秒速时时彩 辽宁快乐12前三开奖号 重庆时时彩计划全天计划小雪